Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association

Circulation. 2016 Dec 6;134(23):e535-e578. doi: 10.1161/CIR.0000000000000450. Epub 2016 Oct 31.
No abstract available

Keywords: AHA Scientific Statements; cardiovascular diseases; comorbidity; diabetes mellitus; heart failure; hyperlipidemia; hypertension; obesity; risk factors.

Publication types

  • Practice Guideline
  • Review

MeSH terms

  • American Heart Association*
  • Cardiology / standards*
  • Chronic Disease
  • Comorbidity
  • Consensus
  • Diabetes Mellitus / diagnosis
  • Diabetes Mellitus / epidemiology
  • Diabetes Mellitus / physiopathology
  • Diabetes Mellitus / therapy*
  • Evidence-Based Medicine
  • Heart Failure / diagnosis
  • Heart Failure / epidemiology
  • Heart Failure / physiopathology
  • Heart Failure / therapy*
  • Humans
  • Hyperlipidemias / diagnosis
  • Hyperlipidemias / epidemiology
  • Hyperlipidemias / physiopathology
  • Hyperlipidemias / therapy*
  • Hypertension / diagnosis
  • Hypertension / epidemiology
  • Hypertension / physiopathology
  • Hypertension / therapy*
  • Incidence
  • Metabolic Syndrome / diagnosis
  • Metabolic Syndrome / epidemiology
  • Metabolic Syndrome / physiopathology
  • Metabolic Syndrome / therapy*
  • Obesity / diagnosis
  • Obesity / epidemiology
  • Obesity / physiopathology
  • Obesity / therapy*
  • Prognosis
  • Risk Assessment
  • Risk Factors
  • United States / epidemiology